Skip to main content

Table 3 Urinary symptoms pre-operatively, 6-months and 1-year following TAH, NDVH and TLH

From: Vaginal, sexual and urinary symptoms following hysterectomy: a multi-centre randomized controlled trial

 TAHNDVHTLHSignificance
Urinary flow symptoms pre-op [median, (IQ1-IQ3)]2 (1–4)3 (2–5)1 (1–4)p = 0.14
Urinary flow symptoms 6-months [median (IQ1-IQ3)]1 (0–3), p < 0.001#2 (0–4.75), p < 0.001#1 (0–3), p < 0.01# 
Urinary flow symptoms 1-year [median (IQ1-IQ3)]1 (0–3), p < 0.001#2 (0.5–4), p < 0.001#1 (0–3), p < 0.05# 
Urinary voiding symptoms pre-op [median, (IQ1-IQ3)]0 (0–0)0 (0–1)0 (0–0)p = 0.25
Urinary voiding symptoms 6-months [median (IQ1-IQ3)]0 (0–0), p = 0.47#0 (0–0.75), p < 0.05#0 (0–0), p = 0.47# 
Urinary voiding symptoms 1-year [median (IQ1-IQ3)]0 (0–0), p = 0.20#0 (0–1), p < 0.05#0 (0–0), p < 0.05# 
Urinary incontinence pre-op [median, (IQ1-IQ3)]symptoms0 (0–2)0 (0–3)0 (0–3)p = 0.25
Urinary incontinence symptoms 6-months [median (IQ1-IQ3)]0 (0–2), p = 0.06#1 (0.75–3), p = 0.07#0 (0–1.75), p = 0.21# 
Urinary incontinence symptoms 1-year [median (IQ1-IQ3)]0 (0–2), p < 0.01#0 (0–3), p < 0.01#0 (0–2), p < 0.05# 
  1. # - p values indicate the significance of the pelvic organ function domain score for the respective route at 6-months and 1-year compared to the pre-operative score
  2. TAH – n = 49 for all at 6-months and n = 47 for all at 1-year
  3. NDVH– n = 48 for all at 6-months and n = 45 for all at 1-year
  4. TLH– n = 48 for all at 6-months and n = 47 for all at 1-year